Company information
- Ticker
- AGL
- Country
- United States
- Sector
- Health Care
- Industry
- Providers
agilon health Business Summary
agilon health, inc. (AGL) operates a full-risk value-based care platform designed to empower independent primary care physicians (PCPs) to manage the total cost and quality of care for senior populations. The company generates nearly all of its revenue through medical services premiums, utilizing a capitation-based model where it receives fixed monthly payments per member from payors in exchange for assuming the financial risk of patient outcomes. Its primary business segments are centered on Medicare Advantage and the ACO REACH (now ACO Model) programs, where it facilitates long-term joint venture partnerships with physician groups. Within the competitive landscape, agilon health competes directly with value-based care enablers like Aledade and Privia Health, as well as vertically integrated giants such as UnitedHealth’s Optum, CVS Health’s Oak Street Health, and Humana. Unlike many competitors that offer fee-for-service or shared-savings options, agilon distinguishes itself by focusing almost exclusively on a high-density, global-risk capitation model for independent practices. The company was founded by industry veterans Ronald A. Williams and Ravi Sachdev, with significant backing from private equity firm Clayton, Dubilier & Rice (CD&R). As of February 2026, agilon is navigating a leadership transition following the August 2025 departure of CEO Steven Sell; the company is currently managed by an "Office of the Chairman" led by Executive Chairman Ronald A. Williams, the former Chairman and CEO of Aetna. Key members of this interim executive team include Chief Financial Officer Jeff Schwaneke, a former Executive Vice President at Centene, and Chief Technology Officer Girish Venkatachaliah, who oversees the company’s proprietary data and analytics platform. The board remains heavily influenced by its founding pedigree, with Ravi Sachdev serving as Vice Chairman and representative of CD&R, alongside other notable directors with deep roots in managed care and clinical leadership.